JDS conceived of the study, was involved Alvocidib manufacturer in drafting the manuscript and participated in its design and coordination. All authors read and approved the final manuscript.”
“Background Intra-abdominal infections (IAIs) include a wide array of pathological conditions, ranging from uncomplicated appendicitis to fecal peritonitis. From a clinical perspective, IAIs are classified in two distinct groups: uncomplicated and complicated infections [1]. In uncomplicated IAIs, the infectious process involves only a single organ and does not extend to the peritoneum. Patients with uncomplicated infections can be treated surgically by means of resection or non-operatively with antibiotic Selleckchem MK 2206 therapy.

When the focus of infection is effectively treated by surgical excision, 24-hour perioperative prophylaxis is typically sufficient. Patients with intra-abdominal infections, including acute diverticulitis and certain forms of acute appendicitis, may be managed non-operatively. In complicated IAIs, the infectious process extends beyond a singly affected organ, and causes either localized

peritonitis (intra-abdominal abscess), or diffuse peritonitis. The treatment of patients with complicated intra-abdominal infections involves both source control and antibiotic therapy. Intra-abdominal infections are further classified as either community-acquired intra-abdominal infections (CA-IAIs) or healthcare-associated intra-abdominal infections (HA-IAIs). CA-IAIs, as the name implies, are acquired directly in the community while HA-IAIs develop in hospitalized patients or residents of long-term healthcare facilities. Of the two, the latter is associated with higher rates

of mortality due to the patients’ poorer underlying health and an increased likelihood of infection by multi-drug resistant microorganisms [2]. Source control encompasses all measures undertaken Interleukin-2 receptor to eliminate the source of infection and control ongoing Captisol clinical trial contamination [3]. The appendix is the most common source of infection in community-acquired intra-abdominal infections, followed closely by the colon and stomach. Dehiscences complicate 5-10% of intra-abdominal bowel anastomoses, and are associated with increased mortality rates [4]. Control of the septic source can be achieved by both operative and non-operative means. Non-operative interventional procedures involve the percutaneous drainage of abscesses. Ultrasound- and CT-guided percutaneous drainage of abdominal and extra-peritoneal abscesses have proven to be safe and effective in select patients [5–12]. Surgery is the most important therapeutic recourse for controlling intra-abdominal infections. Patients suffering from severe peritonitis are prone to persisting intra-abdominal infection, even when the source of infection has been neutralized.